- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Mylab Discovery Solutions unveils combined RT-PCR test kit for chikungunya, dengue, malaria
If a patient goes for individual test of these seven diseases, it could cost around Rs 8,000, but with Mylab's extended monsoon panel, it will cost less than half of the amount, it added.
New Delhi: Biotech firm Mylab Discovery Solutions has announced the launch of its combined RT PCR test kit for diseases, including malaria, chikungunya, dengue, and zika.
The test kit -- PathoDetect Extended Monsoon Fever Panel -- can differentiate malaria, chikungunya, dengue, zika, leishmaniasis, leptospirosis and salmonellosis, the company said in a statement.
If a patient goes for individual test of these seven diseases, it could cost around Rs 8,000, but with Mylab's extended monsoon panel, it will cost less than half of the amount, it added.
Mylab Discovery Solutions founder and managing director Hasmukh Rawal said the precise diagnosis of many of these diseases remains a significant challenge because of the lack of accurate and reliable diagnostic methods.
The 'Extended Monsoon Fever Panel', he said, ''will create a paradigm shift in the diagnosis of seasonal epidemic-prone diseases. Accuracy and speed of diagnosis coupled with its efficiency to distinguish the causative agents will make it an extremely beneficial method to manage these diseases''.
Rawal further said, ''There is a great opportunity for us to use the infrastructure created for control of the COVID-19 virus to monitor the mosquito-borne diseases in elimination programmes. RT-PCR is the most accurate screening solution for detecting vector-borne disease as it was in the case of COVID-19. It can prevent further spread of the diseases and aid in disease elimination.'' The company claimed its combined kit is highly accurate, user-friendly, compact and can process samples to result within 2 hours, therefore, can be implemented for mass testing.
Read also: Shilpa Biologics, Mylab ink pact to enter vaccine, therapeutics segment
Mylab Discovery Solutions Pvt. Ltd., is a Dynamic Biotechnology company, that develops and commercializes diagnostic kits. The company offers a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, agrigenomics and animal and food safety.
Read also: Mylab buys majority stake in POC testing system developers Sanskritech
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751